Industries > Pharma > Biobanking Market Report 2022-2032
Biobanking Market Report 2022-2032
Forecasts by Type (Standalone, Partnership), by Application (Regenerative Medicine, Life Science Research, Clinical Research), by Ownership (National/Regional, Universities, Non-Profit, Private), by Sample Type (Blood Products, Human Tissues, Nucleic Acids, Cell Lines, Biological Fluids, Other), by Product and Service (Equipment, Consumables, Services, Software) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios
The Biobanking Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
A biobank is a place where biological materials that are connected to clinical data are stored. These samples are collected, handled, kept, and processed in compliance with quality standards to benefit society in some kind of a non-profit manner and to promote biomedical research. Large collections of information and biological samples known as biobanks were built specifically for the study. In a number of industries, which would include pharma, academic institutions, livestock breeding, and charitable foundations, these repositories are essential again for advances in medical science into illnesses pathologies as well as demographically experiments within areas of epigenetic mechanisms, preventive services medical programs, chronic illnesses, and epidemiology. Tumor specimens, umbilical, blood, and cerebral spinal fluid are just a few of the several places where biospecimens can be found.
Biobanks Have Emerged Due to Enormous Growth in Scientific Production in Biomedicine During the Past Five Years
Biobanks have increased in size, number, and in some respects, speciation. Biospecimen source guides today include hundreds of biobanks, each with a unique business model for gathering, storing, disseminating, tagging, categorizing, and analyzing specimens (mostly originating from humans) for scientific study. The necessity to combine fundamental and clinical research by promoting cooperative models and the potential to boost informed consent effectiveness because the same genetic material may be used for different purposes led to the emergence of biobanks during the last five years.
What Questions Should You Ask before Buying a Market Research Report?
• How is the biobanking market evolving?
• What is driving and restraining the biobanking market?
• How will each biobanking submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each biobanking submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading biobanking markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the biobanking projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2032? What are the implications of biobanking projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the biobanking market?
• Where is the biobanking market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the biobanking market today, and over the next 10 years:
• Our 553-page report provides 359 tables and 317 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains an in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the biobanking market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
The report delivers exclusive COVID-19 variations and economic data specific to your market.
To access the data contained in this document please email contactus@visiongain.com
Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising biobanking prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Market Segment by Type
• Standalone
• Partnership
Market Segment by Application
• Regenerative Medicine
• Life Science Research
• Clinical Research
Market Segment by Ownership
• National/ Regional
• Universities
• Non-Profit
• Private
Market Segment by Sample Type
• Blood Products
• Human Tissues
• Nucleic Acids
• Cell Lines
• Biological Fluids
• Other Samples
Market Segment by Product and Service
• Equipment
• Consumables
• Services
• Software
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Denmark
• Finland
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Singapore
• Australia
• Rest of Asia Pacific
LAMEA
• Brazil
• Qatar
• Saudi Arabia
• Egypt
• Mexico
• Rest of Latin America
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Biobanking Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• AMS Biotechnology (Europe) Ltd.
• ASKION GmbH
• Avantor, Inc.
• Azenta, Inc. (Azenta)
• Bay Biosciences LLC
• Bioivt & Elevating Science
• Boca Biolistics
• CTI Biotech
• Cureline Inc.
• Firalis SA
• Geneticist Inc.
• Hamilton Bonaduz AG
• Isenet Biobanking
• Merck & Co., Inc.
• ProteoGenex Inc.
• Qiagen NV
• Stemcell Holdings, Inc.
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific Inc.
• US Biolab Corp. Inc.
Overall world revenue for Biobanking Market, 2022 to 2032 in terms of value the market will surpass US$59,347 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Biobanking Market, 2022 to 2032 report help you?
In summary, our 550+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Biobanking Market, 2022 to 2032 Market, with forecasts for type, application, sample type, ownership, product and service, and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2032 for four regional and 20 key national markets – See forecasts for the Biobanking Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 20 of the major companies involved in the Biobanking Market, 2022 to 2032.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Biobanking Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Biobanking Market Report 2022-2032: Forecasts by Type (Standalone, Partnership), by Application (Regenerative Medicine, Life Science Research, Clinical Research), by Ownership (National/Regional, Universities, Non-Profit, Private), by Sample Type (Blood Products, Human Tissues, Nucleic Acids, Cell Lines, Biological Fluids, Other), by Product and Service (Equipment, Consumables, Services, Software) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1.1 Introduction to Biobanking Market
1.2 What are the Objectives of this Report?
1.3 What is the Scope of the Report?
1.4 Biobanking Market Definition
1.5 Why You Should Read This Report
1.6 What This Report Delivers
1.7 Key Questions Answered by This Analytical Report Include:
1.8 Who is This Report for?
1.9 Research Methodology
1.9.1 Primary Research
1.9.2 Secondary Research
1.9.3 Market Evaluation & Forecasting Methodology
1.10 Frequently Asked Questions (FAQs)
1.11 Associated Visiongain Reports
1.12 About Visiongain
2 Executive Summary
3 Biobanking Industry Structure
3.1 Overview
3.1.1 What is Biobank
3.1.2 Key features
3.1.3 Main Components of Biobanking
3.1.4 Types of Samples Collected in Biobanks
3.1.5 Types of Biobanks
3.1.6 History of Biobanks
3.1.7 Biobanking Operations
3.1.8 Objectives of a Biobank
3.1.9 Variability in Biobanks
3.1.10 Setting up a Biobank may be Difficult Given the Complexities of Biospecimen Handling And Maintenance
3.1.11 Biobanking in Health Care: Evolution and Future Directions
4 Global Market Dynamics
4.1 Current Trends in the Global Market
4.1.1 Investment in Information Communication Technologies to Drive Market Growth
4.1.2 Commercialisation of Biobanks’ Brings a Number of Potential Benefits
4.2 Market Driving Factors
4.2.1 Increased Focus on Precision Medicine and Genetic Testing
4.2.2 Growing Demand for Umbilical Cord Blood Banking
4.2.3 Evolution of Biobanks Rapidly Enabling Creation of Massive Collections of Biological Materials and Associated Information
4.3 Market Restraining Factors
4.3.1 Private Sponsorship Has Raised a Number of Ethical Issues
4.3.2 Issues Related to Biospecimen Sample Procurement
4.3.3 Challenges Related to Variability in Biobanks
4.4 Opportunities in the Global Market
4.4.1 Opportunities for Cardiovascular Research
4.4.2 The Pandemic Has Changed All Aspects of Biobanking Industry
4.4.3 Human Biospecimens are Essential for Progress in Biomarker Discovery and Customised Treatment
4.4.4 Growing Focus on the R&D of Cell Therapies
4.5 Challenges in the Global Market
4.5.1 Long-Term Sustainability of Biobanks
4.5.2 Biobanks Facing Familiar Challenges of Improving Design with Limited Resources
4.5.3 Academic Clinical Biobank's Business Plan Should Contain Risk Management and Risk Prognosis
4.6 SWOT Analysis for Global Market
5 Global Biobanking Market Analysis
5.1 Global Market Outlook
5.1.1 List of Biobanks Globally
5.2 Global Market Size Estimation and Forecast
5.2.1 Pre-COVID-19 Market Scenario
5.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Market Size Estimation and Forecast by Region
6.1 Pre-COVID-19 Market Scenario
6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
7 Global Market Size Estimation and Forecast Biobank Type
7.1 Standalone
7.2 Partnership
7.3 Pre-COVID-19 Market Scenario
7.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
8 Global Market Size Estimation and by Application
8.1 Regenerative Medicine
8.2 Life Science Research
8.3 Clinical Research
8.3.1 Treatment Research
8.3.2 Prevention Research
8.3.3 Diagnostic Research
8.3.4 Screening Research
8.3.5 Quality of Life Research
8.3.6 Genetic studies
8.3.7 Epidemiological studies
8.4 Pre-COVID-19 Market Scenario
8.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9 Global Market Size Estimation and Forecast by Ownership
9.1 National/ Regional
9.2 Universities
9.3 Private
9.4 Pre-COVID-19 Market Scenario
9.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10 Global Market Size Estimation and Forecast by Sample Type
10.1 Blood Products
10.2 Human Tissues
10.3 Nucleic Acids
10.4 Cell Lines
10.5 Pre-COVID-19 Market Scenario
10.6 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11 Global Market Size Estimation and Forecast Product and Service
11.1 Equipment
11.2 Consumables
11.3 Services
11.4 Software
11.5 Pre-COVID-19 Market Scenario
11.6 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12 North America Biobanking Market Analysis
12.1 North America Market Size Estimation and Forecast
12.1.1 Pre-COVID-19 Market Scenario
12.1.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.2 North America Market Size Estimation and Forecast by Country
12.2.1 Pre-COVID-19 Market Scenario
12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.3 North America Market Size Estimation and Forecast Type
12.3.1 Pre-COVID-19 Market Scenario
12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.4 North America Market Size Estimation and by "Application
12.4.1 Pre-COVID-19 Market Scenario
12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.5 North America Market Size Estimation and Forecast by Ownership
12.5.1 Pre-COVID-19 Market Scenario
12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.6 North America Market Size Estimation and Forecast by Sample Type
12.6.1 Pre-COVID-19 Market Scenario
12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.7 North America Market Size Estimation and Forecast Product and Service
12.7.1 Pre-COVID-19 Market Scenario
12.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.8 U.S. Biobanking Market Analysis
12.8.1 Biobanking Research and Privacy Laws in the United States
12.8.2 BioLife Solutions Executes Co-Marketing Agreement with Coriell Institute
12.8.3 Pre-COVID-19 Market Scenario
12.8.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.9 Canada Biobanking Market Analysis
12.9.1 Pre-COVID-19 Market Scenario
12.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13 Europe Biobanking Market Analysis
13.1 Europe Market Outlook
13.1.1 REPROCELL Signs Agency Agreement with Ajinomoto Group for the Marketing and Sales of StemFit Basic03 GMP
13.2 Europe Market Size Estimation and Forecast
13.2.1 Pre-COVID-19 Market Scenario
13.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.3 Europe Market Size Estimation and Forecast by Country
13.3.1 Pre-COVID-19 Market Scenario
13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.4 Europe Market Size Estimation and Forecast Type
13.4.1 Pre-COVID-19 Market Scenario
13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.5 Europe Market Size Estimation and by Application
13.5.1 Pre-COVID-19 Market Scenario
13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.6 Europe Market Size Estimation and Forecast by Ownership
13.6.1 Pre-COVID-19 Market Scenario
13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.7 Europe Market Size Estimation and Forecast by Sample Type
13.7.1 Pre-COVID-19 Market Scenario
13.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.8 Europe Market Size Estimation and Forecast Product and Service
13.8.1 Pre-COVID-19 Market Scenario
13.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.9 Germany Biobanking Market Analysis
13.9.1 Pre-COVID-19 Market Scenario
13.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.10 UK Biobanking Market Analysis
13.10.1 Pre-COVID-19 Market Scenario
13.10.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.11 France Biobanking Market Analysis
13.11.1 Pre-COVID-19 Market Scenario
13.11.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.12 Italy Biobanking Market Analysis
13.12.1 Pre-COVID-19 Market Scenario
13.12.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.13 Spain Biobanking Market Analysis
13.13.1 Pre-COVID-19 Market Scenario
13.13.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.14 Russia Biobanking Market Analysis
13.14.1 Pre-COVID-19 Market Scenario
13.14.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.15 Denmark Biobanking Market Analysis
13.15.1 Denmark Launches World-Class Biobank
13.15.2 Pre-COVID-19 Market Scenario
13.15.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.16 Finland Biobanking Market Analysis
13.16.1 FINGENIOUS® – A Digital Gateway to Finnish Biobanks And Biomedical Research
13.16.2 Pre-COVID-19 Market Scenario
13.16.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.17 Rest of Europe Biobanking Market Analysis
13.17.1 Switzerland Seeking to Join Six European Infrastructure Networks
13.17.2 Pre-COVID-19 Market Scenario
13.17.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14 Asia-Pacific Biobanking Market Analysis
14.1 Asia-Pacific Market Outlook
14.1.1 Six Government Agencies Work Together to Run the Korean Public Biobanks
14.2 Asia-Pacific Market Size Estimation and Forecast
14.2.1 Pre-COVID-19 Market Scenario
14.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.3 Asia-Pacific Market Size Estimation and Forecast by Country
14.3.1 Pre-COVID-19 Market Scenario
14.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.4 Asia-Pacific Market Size Estimation and Forecast Type
14.4.1 Pre-COVID-19 Market Scenario
14.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.5 Asia-Pacific Market Size Estimation and by "Application
14.5.1 Pre-COVID-19 Market Scenario
14.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.6 Asia-Pacific Market Size Estimation and Forecast by Ownership
14.6.1 Pre-COVID-19 Market Scenario
14.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.7 Asia-Pacific Market Size Estimation and Forecast by Sample Type
14.7.1 Pre-COVID-19 Market Scenario
14.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.8 Asia-Pacific Market Size Estimation and Forecast by Product and Service
14.8.1 Pre-COVID-19 Market Scenario
14.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.9 China Biobanking Market Analysis
14.9.1 Rapid Expansion of Biobanking in China
14.9.2 Pre-COVID-19 Market Scenario
14.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.10 India Biobanking Market Analysis
14.10.1 Sapien Biosciences: India’s First Commercial Biobank That Helps Develop Novel Diagnostic Tests and Cures
14.10.2 Pre-COVID-19 Market Scenario
14.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.11 Japan Biobanking Market Analysis
14.11.1 Nightingale and BioBank Japan to Realise Personalised Medicine and Preventative Health in Japan
14.11.2 Pre-COVID-19 Market Scenario
14.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.12 Singapore Biobanking Market Analysis
14.12.1 Established Biobank in Singapore
14.12.2 BioBank - National Heart Centre Singapore
14.12.3 Pre-COVID-19 Market Scenario
14.12.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.13 Australia Biobanking Market Analysis
14.13.1 Australia’s First Accredited Biobank
14.13.2 NATA’s Biobanking Accreditation Set to Expand the Emerging Australian Biobanking Industry
14.13.3 Pre-COVID-19 Market Scenario
14.13.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.14 Rest of Asia-Pacific Biobanking Market Analysis
14.14.1 Taiwan Biobank: A Rich Biomedical Research Database of the Taiwanese Population
14.14.2 Pre-COVID-19 Market Scenario
14.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15 LAMEA Biobanking Market Analysis
15.1 LAMEA Market Outlook
15.1.1 Tumor Banking for Health Research in Brazil and Latin America
15.2 LAMEA Market Size Estimation and Forecast
15.2.1 Pre-COVID-19 Market Scenario
15.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.3 LAMEA Market Size Estimation and Forecast by Country
15.3.1 Pre-COVID-19 Market Scenario
15.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.4 LAMEA Market Size Estimation and Forecast Type
15.4.1 Pre-COVID-19 Market Scenario
15.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.5 LAMEA Market Size Estimation and by Application
15.5.1 Pre-COVID-19 Market Scenario
15.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.6 LAMEA Market Size Estimation and Forecast by Ownership
15.6.1 Pre-COVID-19 Market Scenario
15.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.7 LAMEA Market Size Estimation and Forecast by Sample Type
15.7.1 Pre-COVID-19 Market Scenario
15.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.8 LAMEA Market Size Estimation and Forecast Product and Service
15.8.1 Pre-COVID-19 Market Scenario
15.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.9 Egypt Biobanking Market Analysis
15.9.1 Pre-COVID-19 Market Scenario
15.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.10 Qatar Biobanking Market Analysis
15.10.1 Qatar Biobank Launches Online Portal to Provide Researchers with Bio-samples
15.10.2 Qatar Biobank research helps more than 190 projects
15.10.3 Pre-COVID-19 Market Scenario
15.10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.11 Mexico Biobanking Market Analysis
15.11.1 Trans-Hit Bio Has Established New Collaborations With Mexican Biobanks
15.11.2 Pre-COVID-19 Market Scenario
15.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.1 Brazil Biobanking Market Analysis
15.1.1 Current State of Biobanking Activities in Brazil
15.1.2 Pre-COVID-19 Market Scenario
15.1.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.2 Saudi Arabia Biobanking Market Analysis
15.2.1 Pre-COVID-19 Market Scenario
15.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.3 Rest of LAMEA Biobanking Market Analysis
15.3.1 Urgent Need for Management of Biological Samples and Data Accessibility in Latin America
15.3.2 Pre-COVID-19 Market Scenario
15.3.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16 Company Profiles
16.1 QIAGEN
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Company Financial Profile
16.1.4 Company Product Benchmarking
16.2 Merck & Co., Inc
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Company Financial Profile
16.2.4 Company Product Benchmarking
16.3 Avantor Inc.
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Company Financial Profile
16.3.4 Company Product Benchmarking
16.3.5 Company Recent Developments
16.4 STEMCELL Technologies Inc
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Company Product Benchmarking
16.4.4 Company Recent Developments
16.5 Stemcell Holdings, Inc.
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Company Product Benchmarking
16.6 Azenta Life Sciences
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Company Financial Profile
16.6.4 Company Product Benchmarking
16.6.5 Company Recent Developments
16.7 AMS Biotechnology (Europe) Ltd.
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Company Product Benchmarking
16.7.4 Company Recent Developments
16.8 ASKION GmbH
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Company Product Benchmarking
16.8.4 Company Recent Developments
16.9 Bay Biosciences LLC
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Company Product Benchmarking
16.9.4 Company Recent Developments
16.10 Cureline Inc.
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Company Product Benchmarking
16.10.4 Company Recent Developments
16.11 Firalis SA.
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Company Product Benchmarking
16.11.4 Company Recent Developments
16.12 Geneticist Inc..
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Company Product Benchmarking
16.12.4 Company Recent Developments
16.13 Hamilton Bonaduz AG
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Company Product Benchmarking
16.13.4 Company Recent Developments
16.14 ProteoGenex Inc.
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Company Product Benchmarking
16.14.4 Company Recent Developments
16.15 Thermo Fisher Scientific Inc.
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Company Financial Profile
16.15.4 Company Product Benchmarking
16.15.5 Company Recent Developments
16.16 US Biolab Corp. Inc.
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Company Product Benchmarking
16.17 BIOIVT & ELEVATING SCIENCE
16.17.1 Company Snapshot
16.17.2 Company Overview
16.17.3 Company Product Benchmarking
16.17.4 Company Recent Developments
16.18 Boca Biolistics
16.18.1 Company Snapshot
16.18.2 Company Overview
16.18.3 Company Product Benchmarking
16.18.4 Company Recent Developments
16.19 CTI Biotech
16.19.1 Company Snapshot
16.19.2 Company Overview
16.19.3 Company Product Benchmarking
16.19.4 Company Recent Developments
16.20 Isenet Biobanking
16.20.1 Company Snapshot
16.20.2 Company Overview
16.20.3 Company Product Benchmarking
17 Conclusion and Recommendations
17.1 Concluding Remarks
17.2 Recommendations for Market Players
List of Tables
Table 1. Global Biobanking Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2. Biobanking Market Swot Analysis
Table 3. Largest Biobanking In The World
Table 4. List of Europe Biobank
Table 5. List of North and Canada Biobanking
Table 6. List of Asian Biobanks
Table 7. Global Bio banking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 8. Global Biobanking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 9. Global Biobanking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 10. Global Biobanking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 11. Global Biobanking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 12. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 13. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 14. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 15. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 16. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 17. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 18. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 19. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 20. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 21. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 22. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 23. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 24. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 25. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 26. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 27. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 28. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 29. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 30. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 31. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 32. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 33. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 34. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 35. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 36. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 37. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 38. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 39. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 40. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 41. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 42. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 43. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 44. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 45. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 46. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 47. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 48. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 49. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 50. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 51. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 52. North America Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 53. North America Bio banking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 54. North America Bio banking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 55. North America Bio banking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 56. North America Bio banking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 57. North America Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 58. North America Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 59. North America Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 60. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 61. North America Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 62. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 63. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 64. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 65. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 66. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 67. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 68. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 69. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 70. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 71. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 72. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 73. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 74. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 75. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 76. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 77. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 78. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 79. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 80. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 81. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 82. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 83. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 84. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 85. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 86. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 87. Europe Bio banking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 88. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 89. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 90. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 91. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 92. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 93. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 94. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 95. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 96. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 97. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 98. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 99. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 100. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 101. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 102. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 103. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 104. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 105. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 106. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 107. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 108. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 109. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 110. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 111. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 112. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 113. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 114. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 115. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 116. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 117. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 118. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 119. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 120. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 121. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 122. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 123. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 124. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 125. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 126. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 127. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 128. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 129. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 130. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 131. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 132. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 133. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 134. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 135. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 136. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 137. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 138. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 139. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 140. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 141. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 142. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 143. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 144. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 145. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 146. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 147. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 148. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 149. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 150. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 151. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 152. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 153. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 154. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 155. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 156. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 157. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 158. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 159. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 160. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 161. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 162. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 163. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 164. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 165. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 166. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 167. List of Asian Biobanks
Table 168. Korean Biobank List
Table 169. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 170. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 171. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 172. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 173. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 174. Asia-Pacific Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 175. Asia-Pacific Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 176. Asia-Pacific Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 177. Asia-Pacific Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 178. Asia-Pacific Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 179. Asia-Pacific Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 180. Asia-Pacific Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 181. Asia-Pacific Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 182. Asia-Pacific Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 183. Asia-Pacific Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 184. Asia-Pacific Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 185. Asia-Pacific Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 186. Asia-Pacific Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 187. Asia-Pacific Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 188. Asia-Pacific Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 189. Asia-Pacific Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 190. Asia-Pacific Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 191. Asia-Pacific Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 192. Asia-Pacific Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 193. Asia-Pacific Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 194. Asia-Pacific Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 195. Asia-Pacific Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 196. Asia-Pacific Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 197. Asia-Pacific Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 198. Asia-Pacific Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 199. Asia-Pacific Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 200. Asia-Pacific Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 201. Asia-Pacific Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 202. Asia-Pacific Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 203. Asia-Pacific Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 204. China Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 205. China Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 206. China Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 207. China Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 208. China Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 209. India Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 210. India Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 211. India Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 212. India Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 213. India Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 214. Japan Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 215. Japan Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 216. Japan Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 217. Japan Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 218. Japan Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 219. Singapore Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 220. Singapore Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 221. Singapore Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 222. Singapore Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 223. Singapore Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 224. Australia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 225. Australia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 226. Australia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 227. Australia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 228. Australia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 229. Rest of Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 230. Rest of Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 231. Rest of Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 232. Rest of Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 233. Rest of Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 234. LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 235. LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 236. LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 237. LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 238. LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 239. LAMEA Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 240. LAMEA Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V – Shaped Recovery)
Table 241. LAMEA Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W – Shaped Recovery)
Table 242. LAMEA Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U – Shaped Recovery)
Table 243. LAMEA Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 244. LAMEA Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 245. LAMEA Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 246. LAMEA Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 247. LAMEA Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 248. LAMEA Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 249. LAMEA Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 250. LAMEA Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 251. LAMEA Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 252. LAMEA Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 253. LAMEA Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 254. LAMEA Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 255. LAMEA Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 256. LAMEA Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 257. LAMEA Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 258. LAMEA Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 259. LAMEA Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 260. LAMEA Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 261. LAMEA Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 262. LAMEA Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 263. LAMEA Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 264. LAMEA Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 265. LAMEA Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 266. LAMEA Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 267. LAMEA Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 268. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 269. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 270. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 271. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 272. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 273. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 274. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 275. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 276. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 277. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 278. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 279. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 280. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 281. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 282. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 283. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 284. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 285. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 286. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 287. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 288. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 289. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 290. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 291. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 292. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 293. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 294. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 295. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 296. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 297. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 298. Qiagen NV.: Company Information
Table 299. Qiagen NV: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 300. Qiagen NV.: Company Product and Service Benchmarking
Table 301. Merck & Co: Company Information
Table 302. Merck & Co: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 303. Merck & Co: Company Product and Service Benchmarking
Table 304. Avantor, Inc.: Company Information
Table 305. Avantor, Inc: Company Revenue 2017-2021 (US$Mn)
Table 306. Avantor, Inc.: Company Product and Service Benchmarking
Table 307. Avantor Inc: Company Recent Developments
Table 308. STEMCELL Technologies Inc.: Company Information
Table 309. STEMCELL Technologies Inc.: Company Product and Service Benchmarking
Table 310. STEMCELL Technologies Inc.: Company Recent Developments
Table 311. Stemcell Holdings, Inc.: Company Information
Table 312. Stemcell Holdings, Inc: Company Product and Service Benchmarking
Table 313. Azenta, Inc.: Company Information
Table 314. Azenta, Inc: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 315. Azenta, Inc.: Company Product and Service Benchmarking
Table 316. Azenta, Inc.: Company Recent Developments
Table 317. AMS Biotechnology (Europe) Ltd.: Company Information
Table 318. AMS Biotechnology (Europe) Ltd.: Company Product and Service Benchmarking
Table 319. AMS Biotechnology (Europe) Ltd.: Company Recent Developments
Table 320. ASKION GmbH: Company Information
Table 321. ASKION GmbH: Company Product and Service Benchmarking
Table 322. ASKION GmbH: Company Recent Developments
Table 323. Bay Biosciences LLC: Company Information
Table 324. Bay Biosciences LLC: Company Product and Service Benchmarking
Table 325. Bay Biosciences LLC: Company Recent Developments
Table 326. Cureline Inc.: Company Information
Table 327. Cureline Inc.: Company Product and Service Benchmarking
Table 328. Cureline Inc.: Company Recent Developments
Table 329. Firalis SA.: Company Information
Table 330. Firalis SA.: Company Product and Service Benchmarking
Table 331. Firalis SA.: Company Recent Developments
Table 332. Geneticist Inc..: Company Information
Table 333. Geneticist Inc..: Company Product and Service Benchmarking
Table 334. Geneticist Inc..: Company Recent Developments
Table 335. Hamilton Bonaduz AG: Company Information
Table 336. Hamilton Bonaduz AG: Company Product and Service Benchmarking
Table 337. Hamilton Bonaduz AG: Company Recent Developments
Table 338. ProteoGenex Inc.: Company Information
Table 339. ProteoGenex Inc.: Company Product and Service Benchmarking
Table 340. ProteoGenex Inc.: Company Recent Developments
Table 341. Thermo Fisher Scientific Inc..: Company Information
Table 342. Thermo Fisher Scientific Inc..: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 343. Thermo Fisher Scientific Inc..: Company Product and Service Benchmarking
Table 344. Thermo Fisher Scientific Inc..: Company Recent Developments
Table 345. US Biolab Corp. Inc.: Company Information
Table 346. US Biolab Corp. Inc.: Company Product and Service Benchmarking
Table 347. BIOIVT & ELEVATING SCIENCE.: Company Information
Table 348. BIOIVT & ELEVATING SCIENCE.: Company Product and Service Benchmarking
Table 349. BIOIVT & ELEVATING SCIENCE.: Company Recent Developments
Table 350. Boca Biolistics.: Company Information
Table 351. Boca Biolistics.: Company Product and Service Benchmarking
Table 352. Boca Biolistics.: Company Recent Developments
Table 353. CTI Biotech.: Company Information
Table 354. CTI Biotech.: Company Product and Service Benchmarking
Table 355. CTI Biotech.: Company Recent Developments
Table 356. Isenet Biobanking.: Company Information
Table 357. Isenet Biobanking.: Company Product and Service Benchmarking
List of Figures
Figure 1. Global Biobanking Market Segmentation
Figure 2. Current Trends in the Global Market
Figure 3. Global Biobanking Market by Value, 2022-2032 (USD Mn, AGR(%))
Figure 4. Global Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery)
Figure 5. Global Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 6. Global Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 7. Global Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 8. Global Biobanking Market by Region, 2022-2032(USD Mn, AGR(%))
Figure 9. Global Biobanking Market by Region, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 10. Global Biobanking Market by Region, 2022-2032(USD Mn, AGR(%))(W – Shaped Recovery)
Figure 11. Global Biobanking Market by Region, 2022-2032(USD Mn, AGR(%))(U – Shaped Recovery)
Figure 12. Global Biobanking Market by Region, 2022-2032(USD Mn, AGR(%))(L – Shaped Recovery)
Figure 13. Global Biobanking Market Forecast by Type 2022, 2027, 2032 (%)
Figure 14. Global Biobanking Market by Type, 2022-2032(USD Mn, AGR(%))
Figure 15. Global Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery)
Figure 16. Global Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 17. Global Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 18. Global Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 19. Global Biobanking Market by "Application2022-2032(USD Mn, AGR(%))
Figure 20. Global Biobanking Market by "Application2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 21. Global Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 22. Global Biobanking Market by "Application2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 23. Global Biobanking Market by "Application2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 24. Global Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))
Figure 25. Global Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 26. Global Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 27. Global Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 28. Global Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 29. Global Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%))
Figure 30. Global Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 31. Global Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 32. Global Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 33. Global Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 34. Global Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))
Figure 35. Global Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 36. Global Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 37. Global Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 38. Global Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 39. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR(%))
Figure 40. North America Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery)
Figure 41. North America Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 42. North America Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 43. North America Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 44. North America Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))
Figure 45. North America Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 46. North America Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(W – Shaped Recovery)
Figure 47. North America Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(U – Shaped Recovery)
Figure 48. North America Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(L – Shaped Recovery)
Figure 49. North America Biobanking Market by Type, 2022-2032(USD Mn, AGR(%))
Figure 50. North America Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery)
Figure 51. North America Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 52. North America Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 53. North America Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 54. North America Biobanking Market by "Application 2022-2032(USD Mn, AGR(%))
Figure 55. North America Biobanking Market by "Application2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 56. North America Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 57. North America Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 58. North America Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 59. North America Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))
Figure 60. North America Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 61. North America Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 62. North America Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 63. North America Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 64. North America Biobanking Market by Sample Type , 2022-2032(USD Mn, AGR(%))
Figure 65. North America Biobanking Market by Sample Type , 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 66. North America Biobanking Market by Sample Type , 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 67. North America Biobanking Market by Sample Type , 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 68. North America Biobanking Market by Sample Type , 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 69. North America Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))
Figure 70. North America Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 71. North America Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 72. North America Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 73. North America Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 74. US Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 75. US Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 76. US Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 77. US Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 78. US Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 79. Canada Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 80. Canada Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 81. Canada Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 82. Canada Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 83. Canada Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 84. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR(%))
Figure 85. Europe Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery)
Figure 86. Europe Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 87. Europe Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 88. Europe Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 89. Europe Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))
Figure 90. Europe Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 91. Europe Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(W – Shaped Recovery)
Figure 92. Europe Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(U – Shaped Recovery)
Figure 93. Europe Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(L – Shaped Recovery)
Figure 94. Europe Biobanking Market by Type, 2022-2032(USD Mn, AGR(%))
Figure 95. Europe Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery)
Figure 96. Europe Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 97. Europe Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 98. Europe Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 99. Europe Biobanking Market by Application 2022-2032(USD Mn, AGR(%))
Figure 100. Europe Biobanking Market by Application2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 101. Europe Biobanking Market by Application 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 102. Europe Biobanking Market by Application 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 103. Europe Biobanking Market by Application 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 104. Europe Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))
Figure 105. Europe Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 106. Europe Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 107. Europe Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 108. Europe Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 109. Europe Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%))
Figure 110. Europe Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 111. Europe Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 112. Europe Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 113. Europe Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 114. Europe Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))
Figure 115. Europe Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 116. Europe Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 117. Europe Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 118. Europe Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 119. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 120. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 121. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 122. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 123. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 124. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 125. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 126. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 127. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 128. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 129. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 130. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 131. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 132. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 133. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 134. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 135. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 136. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 137. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 138. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 139. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 140. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 141. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 142. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 143. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 144. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 145. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 146. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 147. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 148. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 149. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 150. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 151. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 152. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 153. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 154. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 155. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 156. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 157. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 158. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 159. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 160. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 161. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 162. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 163. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 164. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR(%))
Figure 165. Asia-Pacific Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery)
Figure 166. Asia-Pacific Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 167. Asia-Pacific Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 168. Asia-Pacific Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 169. Asia-Pacific Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))
Figure 170. Asia-Pacific Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 171. Asia-Pacific Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(W – Shaped Recovery)
Figure 172. Asia-Pacific Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(U – Shaped Recovery)
Figure 173. Asia-Pacific Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(L – Shaped Recovery)
Figure 174. Asia-Pacific Biobanking Market by Type, 2022-2032(USD Mn, AGR(%))
Figure 175. Asia-Pacific Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery)
Figure 176. Asia-Pacific Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 177. Asia-Pacific Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 178. Asia-Pacific Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 179. Asia-Pacific Biobanking Market by "Application 2022-2032(USD Mn, AGR(%))
Figure 180. Asia-Pacific Biobanking Market by "Application2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 181. Asia-Pacific Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 182. Asia-Pacific Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 183. Asia-Pacific Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 184. Asia-Pacific Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))
Figure 185. Asia-Pacific Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 186. Asia-Pacific Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 187. Asia-Pacific Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 188. Asia-Pacific Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 189. Asia-Pacific Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%))
Figure 190. Asia-Pacific Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 191. Asia-Pacific Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 192. Asia-Pacific Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 193. Asia-Pacific Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 194. Asia-Pacific Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))
Figure 195. Asia-Pacific Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 196. Asia-Pacific Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 197. Asia-Pacific Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 198. Asia-Pacific Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 199. China Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 200. China Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 201. China Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 202. China Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 203. China Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 204. India Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 205. India Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 206. India Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 207. India Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 208. India Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 209. Japan Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 210. Japan Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 211. Japan Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 212. Japan Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 213. Japan Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 214. Singapore Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 215. Singapore Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 216. Singapore Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 217. Singapore Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 218. Singapore Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 219. Australia Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 220. Australia Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 221. Australia Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 222. Australia Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 223. Australia Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 224. Rest of Asia-Pacific Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 225. Rest of Asia-Pacific Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 226. Rest of Asia-Pacific Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 227. Rest of Asia-Pacific Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 228. Rest of Asia-Pacific Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 229. LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR(%))
Figure 230. LAMEA Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery)
Figure 231. LAMEA Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 232. LAMEA Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 233. LAMEA Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 234. LAMEA Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))
Figure 235. LAMEA Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 236. LAMEA Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(W – Shaped Recovery)
Figure 237. LAMEA Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(U – Shaped Recovery)
Figure 238. LAMEA Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(L – Shaped Recovery)
Figure 239. LAMEA Biobanking Market by Type, 2022-2032(USD Mn, AGR(%))
Figure 240. LAMEA Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery)
Figure 241. LAMEA Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 242. LAMEA Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 243. LAMEA Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 244. LAMEA Biobanking Market by Application 2022-2032(USD Mn, AGR(%))
Figure 245. LAMEA Biobanking Market by Application2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 246. LAMEA Biobanking Market by Application 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 247. LAMEA Biobanking Market by Application 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 248. LAMEA Biobanking Market by Application 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 249. LAMEA Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))
Figure 250. LAMEA Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 251. LAMEA Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 252. LAMEA Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 253. LAMEA Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 254. LAMEA Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%))
Figure 255. LAMEA Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 256. LAMEA Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 257. LAMEA Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 258. LAMEA Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 259. LAMEA Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))
Figure 260. LAMEA Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery)
Figure 261. LAMEA Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery)
Figure 262. LAMEA Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery)
Figure 263. LAMEA Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery)
Figure 264. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 265. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 266. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 267. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 268. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 269. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 270. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 271. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 272. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 273. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 274. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 275. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 276. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))(W – Shaped Recovery)
Figure 277. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 278. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 279. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 280. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))(V – Shaped Recovery)
Figure 281. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 282. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 283. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 284. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 285. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 286. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 287. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 288. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 289. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 290. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery)
Figure 291. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery)
Figure 292. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery)
Figure 293. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery)
Figure 294. Qiagen NV: Company Revenue 2017-2021 (US$Mn, AGR %)
Figure 295. Qiagen NV: Company Operating Income 2017-2021 (US$Mn, AGR %)
Figure 296. Qiagen NV: Company Net Income 2017-2021 (US$Mn, AGR %)
Figure 297. Qiagen NV: Company EBITDA 2017-2021 (US$Mn, AGR %)
Figure 298. Merck & Co: Company Revenue 2017-2021 (US$Mn, AGR %)
Figure 299. Merck & Co: Company Operating Income 2017-2021 (US$Mn, AGR %)
Figure 300. Merck & Co: Company Net Income 2017-2021 (US$Mn, AGR %)
Figure 301. Merck & Co: Company EBITDA 2017-2021 (US$Mn, AGR %)
Figure 302. Azenta, Inc: Company Revenue 2017-2021 (US$Mn, AGR %)
Figure 303. Azenta, Inc: Company Operating Income 2017-2021 (US$Mn, AGR %)
Figure 304. Azenta, Inc: Company Net Income 2017-2021 (US$Mn, AGR %)
Figure 305. Azenta, Inc..: Company EBITDA 2017-2021 (US$Mn, AGR %)
Figure 306. Thermo Fisher Scientific Inc..: Company Revenue 2017-2021 (US$Mn, AGR %)
Figure 307. Thermo Fisher Scientific Inc..: Company Operating Income 2017-2021 (US$Mn, AGR %)
Figure 308. Thermo Fisher Scientific Inc..: Company Net Income 2017-2021 (US$Mn, AGR %)
Figure 309. Thermo Fisher Scientific Inc..: Company EBITDA 2017-2021 (US$Mn, AGR %)
AMS Biotechnology (Europe) Ltd.
ASKION GmbH
Avantor, Inc.
Azenta, Inc. (Azenta)
Bay Biosciences LLC
Bioivt & Elevating Science
Boca Biolistics
CTI Biotech
Cureline Inc.
Firalis SA
Geneticist Inc.
Hamilton Bonaduz AG
Isenet Biobanking
Merck & Co., Inc.
ProteoGenex Inc.
Qiagen NV
Stemcell Holdings, Inc.
STEMCELL Technologies Inc.
Thermo Fisher Scientific Inc.
US Biolab Corp. Inc.
List of Other Companies Mentioned in the report
American CryoStem
Asterand Bioscience
Aurora Biomed
Autoscribe Informatics
AuxoCell Laboratories
AXM Shenyang
BioCells
BIOVIA
Caladrius Biosciences
California Cryobank Stem Cell Services LLC
Cells4Life
Inbiomed
Indivumed
IntegenX
International Stem Cell Corporation
LifeGene
OriGene
Pacific BioStorage
Panasonic Biomedical
Parelsnoer
Pharma Cells
Pharmacells Group
Pharmagene
Pop-Gen National Cohort
Popgen
Precision Bioservices
ProMedDx
ProteoGenex
StarLIMS
Steelgate
Stellacure
StemCyte
Stemgent
StemSave
ViaCord
VidaPlus
List of Associations Mentioned in the Report
American Association of Tissue Banks
Australasian Biospecimen Network (ABN)
Bavarian Red Cross (BRK)
Biobank Ireland Trust
Centro Nazionale per le Risorse Biologiche (CNRB)
Coriell Institute for Medical Research
European Association for Predictive, Preventative & Personalised Medicine (EPMA)
European Health Risk Monitoring (EHRM)
Food and Drug Administration (FDA)
Harvard University
INSERM
Instituto de Salud Carlos III
International Agency for Research on Cancer (IARC)
International Air Transport Association (IATA)
International Society for Biological and Environmental Repositories (ISBER)
National Cancer Institute (NCI)
National Genome Research Network (NGFN)
National Institutes of General Medical Sciences
Northeastern University
Office of Biorepositories and Biospecimen Research (OBBR)
Russian Society for Biobanking and Biopreservation (RSBB)
Sechenov First Moscow Medical University (SFMMU)
Singapore Biobank (SBB)
Singapore Tissue Network (STN)
Spanish National Biobank Network
The Organisation for Economic Co-operation and Development (OECD)
UK Biobank
US Department of Transportation (DOT)
World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Biobanking Market Report 2022-2032
Related reports
-
Biopreservation Market Report 2023-2033
The global Biopreservation market is projected to grow at a CAGR of 9.86% by 2033...Full DetailsPublished: 27 February 2023 -
Lyophilisation in Pharmaceutical Market Report 2023-2033
The lyophilization in pharmaceuticals market is valued at US$252.8 billion in 2022 and is projected to grow at a CAGR...Full DetailsPublished: 15 November 2022 -
Synthetic Biology Market Report 2022-2032
The global synthetic biology market was valued at US$13.8 billion in 2021 and is projected to grow at a CAGR...Full DetailsPublished: 27 July 2022 -
Cancer Biologics Market Report 2021-2031
The global demand for cancer biologics is expected to expand significantly over the projected period, owing to the expanded acceptance...Full DetailsPublished: 04 February 2021 -
Gene Therapy R&D Market Report 2021-2031
Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities,...Full DetailsPublished: 11 June 2021 -
Biological Drug API Manufacturing Services Market Report 2021-2031
Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian...Full DetailsPublished: 07 January 2021 -
Stem Cell Technologies and Applications Market Report 2022-2032
The Stem Cell Technologies and Applications market is projected to grow at a CAGR of 8.9% by 2032....Full DetailsPublished: 01 December 2022 -
Liposomal Drug Delivery Devices Market Report 2022-2032
Global liposomal drug delivery devices market is projected to grow at a CAGR of 10.69% by 2032....Full DetailsPublished: 21 June 2022 -
Biologics Market Report 2022-2032
The global biologics market was valued at US$382.85 billion in 2022 and is projected to grow at a CAGR of...Full DetailsPublished: 04 July 2022 -
Precision Medicine Market Report 2022-2032
The global precision medicine market was valued at US$63,333 million in 2021 and is projected to grow at a CAGR...Full DetailsPublished: 05 July 2022
Download sample pages
Complete the form below to download your free sample pages for Biobanking Market Report 2022-2032
Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Latest Pharma news
Pharmaceutical Contract Manufacturing Market
The global Pharmaceutical Contract Manufacturing market is projected to grow at a CAGR of 11.5% by 2034
30 July 2024
Retinal Gene Therapy Market
The global Retinal Gene Therapy market is projected to grow at a CAGR of 9.6% by 2034
26 July 2024
HIV Drugs and Injectables Market
The global HIV Drugs & Injectables market is projected to grow at a CAGR of 4.6 % by 2034
24 July 2024
Digital Twin Technology in Pharmaceutical Manufacturing Market
The global Digital Twin Technology in Pharmaceutical Manufacturing market is projected to grow at a CAGR of 31.3% by 2034
23 July 2024